Stable | Improved | Progressed | |
---|---|---|---|
152 patients in active group at baseline | |||
120 patients achieved inactive disease | 72 (60.0%) | 15 (12.5%) | 33 (27.5%) |
32 patients sustained active disease | 9 (28.1%) | 5 (15.6%) | 18 (56.3%) |
202 patients in inactive group at baseline | |||
96 patients remained in remission | 53 (55.2%) | 30 (31.3%) | 13 (13.5%) |
106 patients relapsed | 17 (16.0%) | 3 (2.8%) | 86 (81.1%) |